Bringing the fundamentals into focus…
Back to Amylyx Pharmaceuticals, Inc.
How Amylyx Pharmaceuticals, Inc. stacks up
AMLX · against 1,216 other Healthcare companies
Growth
8/ 100
Near the bottom of its peers.
Ranked #1,114 of 1,217 · scores higher than 8% of peers
Bars: peers in each 10-point band of the growth score116 peers with a growth score of 0–9, including AMLX · Click a bar to see the companies
Why growth scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth, which is weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 100% of peers. Revenue growth: -100.0% vs peer median 6.1%
- 3-year revenue growth is not reported, so it is left out of the score.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = AMLX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AMLX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -100.0% | 6.1% | 0% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | Not reported | 5.8% | — | — | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around AMLX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1,114 | 2.5B CNY (≈$349M) | 8 | 27 | |
| 1,114 | 1.9B CNY (≈$262M) | 8 | 24 | |
| 1,114 | 8.1B TWD (≈$251M) | 8 | 69 | |
| 1,114 | 6.9B CNY (≈$967M) | 8 | 26 | |
| 1,114 | 3.7B USD | 8 | 31 | |
| 1,114 | 205M USD | 8 | 36 | |
| 1,114 | 285M USD | 8 | 38 | |
| 1,114 | 2.4B USD | 8 | 27 | |
| 1,114 | 31M USD | 8 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score